LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2022 Results on August 23, 2022

Rhea-AI Summary

LifeVantage Corporation (Nasdaq: LFVN) will release its financial results for the fourth quarter and full fiscal year ending June 30, 2022, on August 23, 2022, after market close. A conference call for investors is scheduled at 2:30 PM MT (4:30 PM ET) on the same day. Investors can participate via phone or listen to a live webcast, with archived access available for 30 days. LifeVantage specializes in nutrigenomics, including dietary supplements and health products like Protandim® and Petandim®.

Positive

• Upcoming financial results release for Q4 and full fiscal year may provide crucial insights to shareholders.
• Scheduled investor conference call allows for direct engagement and transparency with investors.

Negative

• None.

SALT LAKE CITY, Aug. 09, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2022, after the stock market closes on Tuesday, August 23, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, August 30, 2022, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13730454, or (412) 317-6671 from international locations, and entering confirmation code 13730454.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1553804&tp_key=27e50f7b3a. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre-and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+™, ProBio™, and Daily Wellness™ dietary supplements, TrueScience® is the Company's line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

 

FAQ

When will LifeVantage Corporation release its financial results?

LifeVantage Corporation will release its financial results on August 23, 2022, after market close.

What time is LifeVantage's investor conference call?

The investor conference call is scheduled for 2:30 PM Mountain Time (4:30 PM Eastern Time) on August 23, 2022.

How can I listen to LifeVantage's earnings call?

You can listen to LifeVantage's earnings call by dialing (877) 704-4453 (U.S.) or (201) 389-0920 (international), or via the live webcast available on their Investor Relations website.

Is there a replay available for LifeVantage's conference call?

Yes, a telephone replay will be available approximately two hours after the call concludes until August 30, 2022.